Phase 3 STAR Trial of Cytori’s Cell Therapy Completes 48-Week Follow-up Visits
News
The Phase 3 STAR trial investigating the safety and effectiveness of a cell therapy based on adipose-derived regenerative cells (ADRCs) for the treatment of hand dysfunction due to scleroderma has completed ... Read more